Study Shows GSK’s Bexsero Halved UK Meningitis B Cases in First Year
GlaxoSmithKline’s meningitis B vaccine, Bexsero, has shown to have a dramatic impact on meningitis B cases within the UK, according to a real-world evidence study. Approximately a year ago the world’s first national meningitis B vaccination campaign was launched, after 10 months there have been reported cases of meningitis B drop 50% compared to the